{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:58:24Z","timestamp":1791291504584,"version":"4.3.0"},"reference-count":62,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic graft-vs-host disease (GVHD) is a major cause of morbidity and mortality of long-term survivors of allogeneic hemato-poietic cell transplantation (HCT). Chronic GVHD can have features of an autoimmune collagen vascular disease with clinical manifestations similar to autoimmune scleroderma and systemic lupus erythematosus (SLE). However, the pathogenesis of chronic GVHD is poorly understood. It is unclear how autoreactive T and B cells are generated in chronic GVHD recipients. We have recently developed a new chronic GVHD model by transplantation of donor DBA\/2 (H-2d) spleen cells into major histocompatibility complex (MHC)-matched but minor antigen-mismatched sublethally irradiated BALB\/c (H-2d) recipients as well as athymic BALB\/cnu\/nu and adult-thymectomized BALB\/c recipients. Both euthymic and athymic BALB\/c recipients developed high levels of serum IgG autoantibodies, sclerodermatous skin damage, and glomerulonephritis. Disease induction required both donor CD25-CD4+ T and B cells in transplants. In contrast, donor CD25+CD4+ T regulatory (Treg) cells prevented the disease induction. These results indicate that host thymus is not required for induction of chronic GVHD and that quiescent autoreactive T and B cells in transplants from nonautoimmune donors may be activated and expanded to cause chronic GVHD with autoimmune manifestations in allogeneic recipients, and donor Treg cells can suppress this process.<\/jats:p>","DOI":"10.1182\/blood-2005-09-3623","type":"journal-article","created":{"date-parts":[[2005,12,14]],"date-time":"2005-12-14T02:48:10Z","timestamp":1134528490000},"page":"2993-3001","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":186,"title":["Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations"],"prefix":"10.1182","volume":"107","author":[{"given":"Chunyan","family":"Zhang","sequence":"first","affiliation":[{"name":"From the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA; and Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Todorov","sequence":"additional","affiliation":[{"name":"From the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA; and Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA; and Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA; and Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Kandeel","sequence":"additional","affiliation":[{"name":"From the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA; and Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Forman","sequence":"additional","affiliation":[{"name":"From the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA; and Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Strober","sequence":"additional","affiliation":[{"name":"From the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA; and Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defu","family":"Zeng","sequence":"additional","affiliation":[{"name":"From the Beckman Research Institute, City of Hope National Medical Center, Duarte, CA; and Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111819181036800_REF1","doi-asserted-by":"crossref","unstructured":"Sullivan KM. Graft-vs-host disease. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. Malden, MA: Blackwell Science; 2004: 635-664.","DOI":"10.1002\/9780470987070.ch50"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9: 215-233.","DOI":"10.1053\/bbmt.2003.50026"},{"key":"2019111819181036800_REF3","doi-asserted-by":"crossref","unstructured":"Lee SJ. New approaches for preventing and treating chronic graft-versus-host disease. Blood. 2005;105: 4200-4206.","DOI":"10.1182\/blood-2004-10-4023"},{"key":"2019111819181036800_REF4","doi-asserted-by":"crossref","unstructured":"Farag SS. Chronic graft-versus-host disease: where do we go from here? Bone Marrow Transplant. 2004;33: 569-577.","DOI":"10.1038\/sj.bmt.1704410"},{"key":"2019111819181036800_REF5","doi-asserted-by":"crossref","unstructured":"Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after allogeneic bone marrow transplantation: a study of 53 long-term-surviving patients. Transplantation. 1988;46: 238-240.","DOI":"10.1097\/00007890-198808000-00010"},{"key":"2019111819181036800_REF6","unstructured":"Lister J, Messner H, Keystone E, Miller R, Fritzler MJ. Autoantibody analysis of patients with graft versus host disease. J Clin Lab Immunol. 1987;24: 19-23."},{"key":"2019111819181036800_REF7","doi-asserted-by":"crossref","unstructured":"Ratanatharathorn V, Ayash L, Reynolds C, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant. 2003;9: 505-511.","DOI":"10.1016\/S1083-8791(03)00216-7"},{"key":"2019111819181036800_REF8","doi-asserted-by":"crossref","unstructured":"Canninga-van Dijk MR, van der Straaten HM, Fijnheer R, Sanders CJ, van den Tweel JG, Verdonck LF. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood. 2004;104: 2603-2606.","DOI":"10.1182\/blood-2004-05-1855"},{"key":"2019111819181036800_REF9","doi-asserted-by":"crossref","unstructured":"Ferrara J, Antin, J. The pathophysiology of graft-vs-host disease. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. Malden, MA: Blackwell Science; 2004: 353-368.","DOI":"10.1002\/9780470987070.ch27"},{"key":"2019111819181036800_REF10","doi-asserted-by":"crossref","unstructured":"van der Veen FM, Rolink AG, Gleichmann E. Autoimmune disease strongly resembling systemic lupus erythematosus (SLE) in F1 mice undergoing graft-versus-host reaction (GVHR). Adv Exp Med Biol. 1982;149: 669-677.","DOI":"10.1007\/978-1-4684-9066-4_92"},{"key":"2019111819181036800_REF11","doi-asserted-by":"crossref","unstructured":"Morris SC, Cheek RL, Cohen PL, Eisenberg RA. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med. 1990;171: 503-517.","DOI":"10.1084\/jem.171.2.503"},{"key":"2019111819181036800_REF12","doi-asserted-by":"crossref","unstructured":"Via CS, Shearer GM. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol Today. 1988;9: 207-213.","DOI":"10.1016\/0167-5699(88)91215-7"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Morris SC, Cheek RL, Cohen PL, Eisenberg RA. Allotype-specific immunoregulation of autoantibody production by host B cells in chronic graft-versus host disease. J Immunol. 1990;144: 916-922.","DOI":"10.4049\/jimmunol.144.3.916"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Sekiguchi DR, Jainandunsing SM, Fields ML, et al. Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol. 2002;168: 4142-4153.","DOI":"10.4049\/jimmunol.168.8.4142"},{"key":"2019111819181036800_REF15","doi-asserted-by":"crossref","unstructured":"Sekiguchi DR, Eisenberg RA, Weigert M. Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells. J Exp Med. 2003;197: 27-39.","DOI":"10.1084\/jem.20020737"},{"key":"2019111819181036800_REF16","doi-asserted-by":"crossref","unstructured":"Parkman R. Clonal analysis of murine graft-vs-host disease, I: phenotypic and functional analysis of T lymphocyte clones. J Immunol. 1986;136: 3543-3548.","DOI":"10.4049\/jimmunol.136.10.3543"},{"key":"2019111819181036800_REF17","doi-asserted-by":"crossref","unstructured":"Jaffee BD, Claman HN. Chronic graft-versus-host disease (GVHD) as a model for scleroderma, I: description of model systems. Cell Immunol. 1983;77: 1-12.","DOI":"10.1016\/0008-8749(83)90001-1"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Claman HN, Jaffee BD, Huff JC, Clark RA. Chronic graft-versus-host disease as a model for scleroderma, II: mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol. 1985;94: 73-84.","DOI":"10.1016\/0008-8749(85)90086-3"},{"key":"2019111819181036800_REF19","doi-asserted-by":"crossref","unstructured":"Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol. 2002;168: 3088-3098.","DOI":"10.4049\/jimmunol.168.6.3088"},{"key":"2019111819181036800_REF20","doi-asserted-by":"crossref","unstructured":"Hamilton BL. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens. J Immunol. 1987;139: 2511-2515.","DOI":"10.4049\/jimmunol.139.8.2511"},{"key":"2019111819181036800_REF21","doi-asserted-by":"crossref","unstructured":"Liang Y, Huang T, Zhang C, et al. Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb. Blood. 2005;105: 2180-2188.","DOI":"10.1182\/blood-2004-06-2411"},{"key":"2019111819181036800_REF22","doi-asserted-by":"crossref","unstructured":"Zeng D, Liu Y, Sidobre S, Kronenberg M, Strober S. Activation of natural killer T cells in NZB\/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest. 2003;112: 1211-1222.","DOI":"10.1172\/JCI200317165"},{"key":"2019111819181036800_REF23","doi-asserted-by":"crossref","unstructured":"Zeng D, Lewis D, Dejbakhsh-Jones S, et al. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med. 1999;189: 1073-1081.","DOI":"10.1084\/jem.189.7.1073"},{"key":"2019111819181036800_REF24","doi-asserted-by":"crossref","unstructured":"Zeng D, Dick M, Cheng L, et al. Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J Exp Med. 1998;187: 525-536.","DOI":"10.1084\/jem.187.4.525"},{"key":"2019111819181036800_REF25","doi-asserted-by":"crossref","unstructured":"Zeng D, Lee MK, Tung J, Brendolan A, Strober S. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB\/NZW mice. J Immunol. 2000;164: 5000-5004.","DOI":"10.4049\/jimmunol.164.10.5000"},{"key":"2019111819181036800_REF26","doi-asserted-by":"crossref","unstructured":"Via CS, Sharrow SO, Shearer GM. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol. 1987;139: 1840-1849.","DOI":"10.4049\/jimmunol.139.6.1840"},{"key":"2019111819181036800_REF27","doi-asserted-by":"crossref","unstructured":"Pierres M, Rebouah JP, Liabeuf A, Dosseto M. Mouse monoclonal antibody against Lyt-1.1 alloantigen. J Immunogenet. 1981;8: 67-71.","DOI":"10.1111\/j.1744-313X.1981.tb01073.x"},{"key":"2019111819181036800_REF28","doi-asserted-by":"crossref","unstructured":"Anderson BE, McNiff JM, Matte C, Athanasiadis I, Shlomchik WD, Shlomchik MJ. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood. 2004;104: 1565-1573.","DOI":"10.1182\/blood-2004-01-0328"},{"key":"2019111819181036800_REF29","doi-asserted-by":"crossref","unstructured":"Chen F, Maldonado MA, Madaio M, Eisenberg RA. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. J Immunol. 1998;161: 5880-5885.","DOI":"10.4049\/jimmunol.161.11.5880"},{"key":"2019111819181036800_REF30","doi-asserted-by":"crossref","unstructured":"Choudhury A, Maldonado MA, Cohen PL, Eisenberg RA. The role of host CD4 T cells in the pathogenesis of the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol. 2005;174: 7600-7609.","DOI":"10.4049\/jimmunol.174.12.7600"},{"key":"2019111819181036800_REF31","doi-asserted-by":"crossref","unstructured":"Parkman R. Chronic graft-versus-host disease. Curr Opin Hematol. 1998;5: 22-25.","DOI":"10.1097\/00062752-199801000-00004"},{"key":"2019111819181036800_REF32","doi-asserted-by":"crossref","unstructured":"Tsoi MS, Storb R, Jones E, et al. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J Immunol. 1978;120: 1485-1492.","DOI":"10.4049\/jimmunol.120.5.1485"},{"key":"2019111819181036800_REF33","doi-asserted-by":"crossref","unstructured":"Hahn BH. Antibodies to DNA. N Engl J Med. 1998;338: 1359-1368.","DOI":"10.1056\/NEJM199805073381906"},{"key":"2019111819181036800_REF34","doi-asserted-by":"crossref","unstructured":"Kotzin BL. Systemic lupus erythematosus. Cell. 1996;85: 303-306.","DOI":"10.1016\/S0092-8674(00)81108-3"},{"key":"2019111819181036800_REF35","doi-asserted-by":"crossref","unstructured":"Huang CM, Parsons M, Oi VT, Huang HJ, Herzenberg LA. Genetic characterization of mouse immunoglobulin allotypic determinants (allotopes) defined by monoclonal antibodies. Immunogenetics. 1983;18: 311-321.","DOI":"10.1007\/BF00372464"},{"key":"2019111819181036800_REF36","doi-asserted-by":"crossref","unstructured":"Anderson RE, Olson GB, Autry JR, Howarth JL, Troup GM, Bartels PH. Radiosensitivity of T and B lymphocytes, IV: effect of whole body irradiation upon various lymphoid tissues and numbers of recirculating lymphocytes. J Immunol. 1977;118: 1191-1200.","DOI":"10.4049\/jimmunol.118.4.1191"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Durum SK, Gengozian N. The comparative radiosensitivity of T and B lymphocytes. Int J Radiat Biol Relat Stud Phys Chem Med. 1978;34: 1-15.","DOI":"10.1080\/09553007814550581"},{"key":"2019111819181036800_REF38","doi-asserted-by":"crossref","unstructured":"Pazdernik TL, Nishimura T. Radiosensitivity of different B and T subpopulations of lymphocytes in the mouse spleen. Agents Actions. 1978;8: 229-237.","DOI":"10.1007\/BF01966608"},{"key":"2019111819181036800_REF39","doi-asserted-by":"crossref","unstructured":"Fukushi N, Arase H, Wang B, et al. Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. Proc Natl Acad Sci U S A. 1990;87: 6301-6305.","DOI":"10.1073\/pnas.87.16.6301"},{"key":"2019111819181036800_REF40","doi-asserted-by":"crossref","unstructured":"Desbarats J, Lapp WS. Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions. J Exp Med. 1993;178: 805-814.","DOI":"10.1084\/jem.178.3.805"},{"key":"2019111819181036800_REF41","doi-asserted-by":"crossref","unstructured":"Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196: 401-406.","DOI":"10.1084\/jem.20020090"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196: 389-399.","DOI":"10.1084\/jem.20020399"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Edinger M, Hoffmann P, Ermann J, et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9: 1144-1150.","DOI":"10.1038\/nm915"},{"key":"2019111819181036800_REF44","doi-asserted-by":"crossref","unstructured":"Zeng D, Lan F, Hoffmann P, Strober S. Suppression of graft-versus-host disease by naturally occurring regulatory T cells. Transplantation. 2004;77: S9-S11.","DOI":"10.1097\/01.TP.0000106475.38978.11"},{"key":"2019111819181036800_REF45","doi-asserted-by":"crossref","unstructured":"Jacob CO, van der Meide PH, McDevitt HO. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med. 1987;166: 798-803.","DOI":"10.1084\/jem.166.3.798"},{"key":"2019111819181036800_REF46","doi-asserted-by":"crossref","unstructured":"Datta SK, Patel H, Berry D. Induction of a cationic shift in IgG anti-DNA autoantibodies: role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J Exp Med. 1987;165: 1252-1268.","DOI":"10.1084\/jem.165.5.1252"},{"key":"2019111819181036800_REF47","doi-asserted-by":"crossref","unstructured":"Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant. 2001;28: 121-129.","DOI":"10.1038\/sj.bmt.1703111"},{"key":"2019111819181036800_REF48","doi-asserted-by":"crossref","unstructured":"Tivol E, Komorowski R, Drobyski WR. Emergent autoimmunity in graft versus host disease. Blood. 2005;105: 4885-4891.","DOI":"10.1182\/blood-2004-12-4980"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Hollander GA, Widmer B, Burakoff SJ. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J Immunol. 1994;152: 1609-1617.","DOI":"10.4049\/jimmunol.152.4.1609"},{"key":"2019111819181036800_REF50","doi-asserted-by":"crossref","unstructured":"Miura Y, Thoburn CJ, Bright EC, et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood. 2004;104: 2187-2193.","DOI":"10.1182\/blood-2004-03-1040"},{"key":"2019111819181036800_REF51","doi-asserted-by":"crossref","unstructured":"Hakim FT, Payne S, Shearer GM. Recovery of T cell populations after acute graft-vs-host reaction. J Immunol. 1994;152: 58-64.","DOI":"10.4049\/jimmunol.152.1.58"},{"key":"2019111819181036800_REF52","doi-asserted-by":"crossref","unstructured":"Klein L, Klugmann M, Nave KA, Tuohy VK, Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med. 2000;6: 56-61.","DOI":"10.1038\/71540"},{"key":"2019111819181036800_REF53","unstructured":"Schultz KR, Paquet J, Bader S, HayGlass KT. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease. Bone Marrow Transplant. 1995;16: 289-295."},{"key":"2019111819181036800_REF54","doi-asserted-by":"crossref","unstructured":"Bendelac A, Bonneville M, Kearney JF. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol. 2001;1: 177-186.","DOI":"10.1038\/35105052"},{"key":"2019111819181036800_REF55","unstructured":"Melchers F, Rolink, A. B-lymphocyte development and biology. In: Paul W, ed. Fundamental Immunology. Philadelphia, PA: Lippincott-Raven; 1998: 367-409."},{"key":"2019111819181036800_REF56","doi-asserted-by":"crossref","unstructured":"Lin RH, Mamula MJ, Hardin JA, Janeway CA Jr. Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med. 1991;173: 1433-1439.","DOI":"10.1084\/jem.173.6.1433"},{"key":"2019111819181036800_REF57","doi-asserted-by":"crossref","unstructured":"Roosnek E, Lanzavecchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med. 1991;173: 487-489.","DOI":"10.1084\/jem.173.2.487"},{"key":"2019111819181036800_","doi-asserted-by":"crossref","unstructured":"Singh RR, Hahn BH. Reciprocal T-B determinant spreading develops spontaneously in murine lupus: implications for pathogenesis. Immunol Rev. 1998;164: 201-208.","DOI":"10.1111\/j.1600-065X.1998.tb01221.x"},{"key":"2019111819181036800_REF59","doi-asserted-by":"crossref","unstructured":"Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med. 1999;189: 1639-1648.","DOI":"10.1084\/jem.189.10.1639"},{"key":"2019111819181036800_REF60","doi-asserted-by":"crossref","unstructured":"Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol. 2001;1: 147-153.","DOI":"10.1038\/35100573"},{"key":"2019111819181036800_REF61","doi-asserted-by":"crossref","unstructured":"La Cava A, Ebling FM, Hahn BH. Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol. 2004;173: 3542-3548.","DOI":"10.4049\/jimmunol.173.5.3542"},{"key":"2019111819181036800_REF62","doi-asserted-by":"crossref","unstructured":"Zheng SG, Wang JH, Koss MN, Quismorio F Jr, Gray JD, Horwitz DA. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol. 2004;172: 1531-1539.","DOI":"10.4049\/jimmunol.172.3.1531"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/7\/2993\/1338849\/zh800706002993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/7\/2993\/1338849\/zh800706002993.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T18:43:13Z","timestamp":1706812993000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/7\/2993\/132067\/Donor-CD4-T-and-B-cells-in-transplants-induce"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-09-3623","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,1]]}}}